<p>The U-2 OS cell line demonstrates moderately increased chemoresistance to a few drugs associated to MDR, such as doxorubicin (panel A) and mitoxantrone (panel D). The HeLa cell line was used as a non-chemoresistant control specimen. Cells were seeded in 96 well plates, treated with the different doses of indicated drugs, and a standard MTT viability test was performed 1 and 2 days post-treatment. Results are presented as a ratio of the OD<sub>595</sub> of treated cells to the OD<sub>595</sub> of the untreated cells.</p
<p>(A) MV4-11 cells were treated with 3 µM SYC-522 and (B–D) other cell lines were treated with 10 µ...
A)-C) Colony survival assays of bladder cancer cell lines RT112 and T24. Cells were treated without ...
<p>(A) Percentage of cell viability inhibition of rhabdospheres compared to native RD after treatmen...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>(A) Sensitization of MA cells to chemotherapeutic drugs by prior treatment with sodium valproate....
<p>Viability of 4T1 or FL4T1 cells was assessed by the MTT assay after treatment with: doxorubicin f...
The development of resistance to antineoplastic drugs is a major obstacle in the treatment of cancer...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with doxorubicin for 24 h...
<p><b>A</b>. Intracellular doxorubicin (Dox) concentrations in MDR− cells (HT29, A549 and MCF7), in ...
<p>Cells (4,000/well) were plated in 96-well plates and pretreated with MBO-asGCS (50 nM). After 24 ...
Methoxymorpholino doxorubicin (MMRDX) is an anthracycline analogue that is able to overcome tumor ce...
The significant differences in the treatment compared to control group and MCF7 compared to HUVEC we...
<p><i>A,</i> SHRs were implanted with SST-2 cells and 24 h later were administered either doxorubici...
<p><b>A</b>) Cells (5×10<sup>3</sup> cells/well) were seeded in 96-well plates and treated with incr...
<p>A panel of cancer cell lines (black color) and a normal liver hepatocyte cell line (red color) we...
<p>(A) MV4-11 cells were treated with 3 µM SYC-522 and (B–D) other cell lines were treated with 10 µ...
A)-C) Colony survival assays of bladder cancer cell lines RT112 and T24. Cells were treated without ...
<p>(A) Percentage of cell viability inhibition of rhabdospheres compared to native RD after treatmen...
<p>(A) Cytotoxic activity of compounds <b>1</b>, <b>2</b>, and <b>5</b> against cancer cells. The in...
<p>(A) Sensitization of MA cells to chemotherapeutic drugs by prior treatment with sodium valproate....
<p>Viability of 4T1 or FL4T1 cells was assessed by the MTT assay after treatment with: doxorubicin f...
The development of resistance to antineoplastic drugs is a major obstacle in the treatment of cancer...
<p>Viability of MDA-MB-231 cells was assessed by MTT assay after treatment with doxorubicin for 24 h...
<p><b>A</b>. Intracellular doxorubicin (Dox) concentrations in MDR− cells (HT29, A549 and MCF7), in ...
<p>Cells (4,000/well) were plated in 96-well plates and pretreated with MBO-asGCS (50 nM). After 24 ...
Methoxymorpholino doxorubicin (MMRDX) is an anthracycline analogue that is able to overcome tumor ce...
The significant differences in the treatment compared to control group and MCF7 compared to HUVEC we...
<p><i>A,</i> SHRs were implanted with SST-2 cells and 24 h later were administered either doxorubici...
<p><b>A</b>) Cells (5×10<sup>3</sup> cells/well) were seeded in 96-well plates and treated with incr...
<p>A panel of cancer cell lines (black color) and a normal liver hepatocyte cell line (red color) we...
<p>(A) MV4-11 cells were treated with 3 µM SYC-522 and (B–D) other cell lines were treated with 10 µ...
A)-C) Colony survival assays of bladder cancer cell lines RT112 and T24. Cells were treated without ...
<p>(A) Percentage of cell viability inhibition of rhabdospheres compared to native RD after treatmen...